IBDEI0N1 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11279,1,5,0)
 ;;=5^Cellulitis Of Leg
 ;;^UTILITY(U,$J,358.3,11279,2)
 ;;=^271894
 ;;^UTILITY(U,$J,358.3,11280,0)
 ;;=682.1^^64^695^9
 ;;^UTILITY(U,$J,358.3,11280,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11280,1,4,0)
 ;;=4^682.1
 ;;^UTILITY(U,$J,358.3,11280,1,5,0)
 ;;=5^Cellulitis Of Neck
 ;;^UTILITY(U,$J,358.3,11280,2)
 ;;=^271889
 ;;^UTILITY(U,$J,358.3,11281,0)
 ;;=376.01^^64^695^10
 ;;^UTILITY(U,$J,358.3,11281,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11281,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,11281,1,5,0)
 ;;=5^Cellulitis Of Orbit
 ;;^UTILITY(U,$J,358.3,11281,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,11282,0)
 ;;=681.10^^64^695^11
 ;;^UTILITY(U,$J,358.3,11282,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11282,1,4,0)
 ;;=4^681.10
 ;;^UTILITY(U,$J,358.3,11282,1,5,0)
 ;;=5^Cellulitis Of Toe
 ;;^UTILITY(U,$J,358.3,11282,2)
 ;;=^271885
 ;;^UTILITY(U,$J,358.3,11283,0)
 ;;=682.2^^64^695^12
 ;;^UTILITY(U,$J,358.3,11283,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11283,1,4,0)
 ;;=4^682.2
 ;;^UTILITY(U,$J,358.3,11283,1,5,0)
 ;;=5^Cellulitis Of Trunk
 ;;^UTILITY(U,$J,358.3,11283,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,11284,0)
 ;;=070.1^^64^695^26
 ;;^UTILITY(U,$J,358.3,11284,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11284,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,11284,1,5,0)
 ;;=5^Hepatitis A 
 ;;^UTILITY(U,$J,358.3,11284,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,11285,0)
 ;;=070.30^^64^695^27
 ;;^UTILITY(U,$J,358.3,11285,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11285,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,11285,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,11285,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,11286,0)
 ;;=070.32^^64^695^28
 ;;^UTILITY(U,$J,358.3,11286,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11286,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,11286,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,11286,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,11287,0)
 ;;=070.51^^64^695^29
 ;;^UTILITY(U,$J,358.3,11287,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11287,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,11287,1,5,0)
 ;;=5^Hepatitis C, Acute
 ;;^UTILITY(U,$J,358.3,11287,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,11288,0)
 ;;=070.54^^64^695^30
 ;;^UTILITY(U,$J,358.3,11288,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11288,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,11288,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,11288,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,11289,0)
 ;;=571.41^^64^695^32
 ;;^UTILITY(U,$J,358.3,11289,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11289,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,11289,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,11289,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,11290,0)
 ;;=571.1^^64^695^33
 ;;^UTILITY(U,$J,358.3,11290,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11290,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,11290,1,5,0)
 ;;=5^Hepatitis, ETOH acute
 ;;^UTILITY(U,$J,358.3,11290,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,11291,0)
 ;;=070.59^^64^695^34
 ;;^UTILITY(U,$J,358.3,11291,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11291,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,11291,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,11291,2)
 ;;=Hepatitis, Other Viral^266631
 ;;^UTILITY(U,$J,358.3,11292,0)
 ;;=V08.^^64^695^24
 ;;^UTILITY(U,$J,358.3,11292,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11292,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,11292,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,11292,2)
 ;;=HIV + Status (Asymptomatic)^303392
 ;;^UTILITY(U,$J,358.3,11293,0)
 ;;=042.^^64^695^25
